Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period.

Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period. Abstract Text:

M KERLAN,

Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period. Publishing Authors By Initials

M KERLAN,

For similar organic chemicals: urea research abstracts see: organic chemicals: urea research

PUBMED ID PMID:

MEDLINE DATE:

Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Journal of the Tennessee State Medical Associa

VOLUME: 50

Page Numbers: 46-8

Journal Abbreviation:

ISSN: 0735-7338

DAY: 24

MONTH: Feb

YEAR: 1957

Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 21130210

Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period. Keywords Mesh Terms:

KEYWORDS: Urea

MESH TERMS: analogs & derivatives

Chemical & Substance for Abstract: Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period. Information

Substance Name: sulfanilamide

Registry Number: 63-74-1

Grant and Affiliation Information for Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Tn State Med Assoc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period Related Publications

• Conditioning for skiing and ski injury prevention.
• Dealing with catheters of excessive length.
• Foods, drugs and the federal law.
• Hepatic vascular anatomy on magnetic resonance imaging.
• Interventional biliary radiology.
• Management of portal venous complications after liver transplantation.
• Massive abdominal wall hemorrhage from injury to the inferior epigastric artery: a retrospective review.
• Reperfusion of pulmonary arteriovenous malformations after successful embolotherapy with vascular plugs.
• Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologic correlation.
• The Federal Food, Drug and Cosmetic Act; its achievements with respect to dental products.
• Therapeutic devices under the Federal Food, Drug and Cosmetic Act.
• Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period.